NCT02040792View on ClinicalTrials.gov

A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
COPD
Interventions
DRUG

TD-4208

DRUG

Placebo

Trial Locations (1)

29615

Upstate Pharmaceutical Research, Greenville

Sponsors

Lead Sponsor

Mylan Inc.

Collaborators (1)

Theravance Biopharma
All Listed Sponsors
collaborator

Theravance Biopharma

INDUSTRY

lead

Mylan Inc.

INDUSTRY